Pharmacokinetic differences between Caucasian and Japanese subjects after single and multiple doses of a potential combined oral contraceptive (Org 30659 and EE).

Abstract:

OBJECTIVES:To compare the pharmacokinetic parameters and safety of the progestagen, Org 30659, (17alpha)-17-hydroxy-11-methylene-19-norpregna-4,15-dien-20-yn-3-one), and ethinyl estradiol (EE) in Caucasian and Japanese women after single and multiple doses. METHODS:This was an open-label parallel design of a single dose followed by a multiple dose period in healthy young Japanese and Caucasian subjects. RESULTS:The area under the curve (AUC) of Org 30659 after single dosing was increased by a factor of 1.75 [90% confidence interval (CI): 1.48-2.08] in Japanese women compared to Caucasian women. At steady state, this difference increased to a factor of 1.90 (90% CI: 1.60-2.25). The AUC of EE after single dosing was similar in Caucasian and Japanese women, but at steady state it was increased by a factor 1.38 (90% CI: 1.15-1.64) in the Japanese group. Weight normalization reduced, but did not remove, all the observed differences. Sex hormone binding globulin played no significant role in the differences between Caucasian and Japanese subjects. Both the single- and multiple-dose treatments with Org 30659/EE were generally well tolerated by all subjects. The Japanese population reported more and different treatment-related adverse events than the Caucasian population. CONCLUSIONS:The peak concentration and extent of exposure of Org 30659, and to a lesser extent of EE, in Japanese women are higher than in Caucasian women. Furthermore, the peak concentration and extent of exposure at steady state of Org 30659, and to a lesser extent of EE, are higher than would be predicted assuming linear pharmacokinetics over time. No major safety issues were observed.

journal_name

Contraception

journal_title

Contraception

authors

de Visser SJ,Uchida N,van Vliet-Daskalopoulou E,Fukazawa I,van Doorn MB,van den Heuvel MW,Machielsen CS,Uchida E,Cohen AF

doi

10.1016/s0010-7824(03)00140-9

subject

Has Abstract

pub_date

2003-09-01 00:00:00

pages

195-202

issue

3

eissn

0010-7824

issn

1879-0518

pii

S0010782403001409

journal_volume

68

pub_type

杂志文章
  • The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids.

    abstract::Patients taking anticonvulsants such as phenobarbitone, phenytoin and carbamazepine together with their oral contraceptive steroid may suffer contraceptive failure because of the enzyme-inducing properties of these anticonvulsants. We have examined, in six women, the effect of sodium valproate, an effective broad spec...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(86)90028-4

    authors: Crawford P,Chadwick D,Cleland P,Tjia J,Cowie A,Back DJ,Orme ML

    更新日期:1986-01-01 00:00:00

  • Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries.

    abstract::The clinical performance of the Copper T 380A (TCu 380A) and the Lippes Loop intrauterine devices (IUDs) were evaluated for 12 months in a group of 710 women who had one of the two IUDs inserted. Results are from a randomized clinical trial conducted at three collaborating research sites located in three developing co...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1016/0010-7824(95)00119-u

    authors: Farr G,Amatya R,Acosta M,Ekwempu C,Kisninci H

    更新日期:1995-07-01 00:00:00

  • Exposure to routine availability of immediate postpartum LARC: effect on attitudes and practices of labor and delivery and postpartum nurses.

    abstract:OBJECTIVES:Nurses play an integral role in intrapartum and postpartum patient education. This exploratory study aims to assess the attitudes, knowledge, and practices of labor and delivery and postpartum nurses regarding contraception and evaluate for changes in these measures 1 year after an institutional initiative a...

    journal_title:Contraception

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.contraception.2018.01.017

    authors: Benfield N,Hawkins F,Ray L,McGowan A,Floyd K,Africa D,Barreto M,Levi E

    更新日期:2018-05-01 00:00:00

  • Hormonal contraception, breastfeeding and bedside advocacy: the case for patient-centered care.

    abstract::Postpartum contraceptive decision making is complex, and recommendations may be influenced by breastfeeding intentions. While biologically plausible, concerns about the adverse impact of hormonal contraception on breast milk production have not been supported by the clinical evidence to date. However, the data have li...

    journal_title:Contraception

    pub_type: 社论

    doi:10.1016/j.contraception.2018.10.011

    authors: Bryant AG,Lyerly AD,DeVane-Johnson S,Kistler CE,Stuebe AM

    更新日期:2019-02-01 00:00:00

  • Effects of gossypol on the kidney with special emphasis on potassium (K) excretion.

    abstract::The overall and renal toxicity of racemic gossypol acetic acid was assessed in 6 mongrel dogs. Oral racemic gossypol acetic acid was given orally at doses increasing from 10 to 40 mg/d for a total of 6 weeks in 3 female dogs and from 40 to 80 mg/d for a total of 4 weeks in 3 male dogs. The animals were then sacrificed...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(88)90127-8

    authors: van Ypersele de Strihou C,Dieu JP,Marbaix E

    更新日期:1988-02-01 00:00:00

  • Lower risk for Down syndrome associated with longer oral contraceptive use: a case-control study of women of advanced maternal age presenting for prenatal diagnosis.

    abstract:BACKGROUND:Maternal trisomy 21 ovarian mosaicism might provide the major causative factor for fetal Down syndrome. The small proportion of trisomy 21 oocytes thought to be retarded in their maturation in comparison to normal disomic ones, and the maternal age effect can be based on an accumulation of trisomy 21 oocytes...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2012.08.040

    authors: Nagy GR,Győrffy B,Nagy B,Rigó J Jr

    更新日期:2013-04-01 00:00:00

  • Triphasic combination of ethinyl estradiol and gestodene. Long-term clinical trial.

    abstract::A triphasic oral contraceptive containing ethinyl estradiol and gestodene was used by 1933 women for up to 36 cycles in order to evaluate contraceptive efficacy, general tolerance and cycle control. Altogether, 30,763 treatment cycles were recorded. Two pregnancies were seen, both of them classified as user failure. T...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/0010-7824(92)90128-g

    authors: Weber-Diehl F,Unger R,Lachnit U

    更新日期:1992-07-01 00:00:00

  • Intrauterine devices and endometrial cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.

    abstract::The relationship between intrauterine device (IUD) use and the development of endometrial cancer was assessed in data from seven countries that were collected between 1979 and 1988 for a multinational hospital-based case-control study. Two hundred twenty-six cases of endometrial cancer were compared with 1,529 control...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(96)00199-0

    authors: Rosenblatt KA,Thomas DB

    更新日期:1996-12-01 00:00:00

  • The influence of hormonal contraceptives on sex hormone binding globulin (SHBG) capacity.

    abstract::The influence of oral contraceptives (OCs) on sex hormone binding globulin (SHBG) capacity was studied in women using OCs for a at least 2 months and compared with values in normal menstruating women, in pregnant women, in postmenopausal women, and in normal males. Binding capacity was measured by ammonium sulfate p...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(75)90050-5

    authors: van Kammen E,Thijssen JH,Rademaker B,Schwarz F

    更新日期:1975-01-01 00:00:00

  • FDA requirements for nonclinical testing of contraceptive steroids.

    abstract::Written guidelines for the preclinical testing of contraceptive steroids have not been revised since 1968 despite the fact that many important changes have been implemented by the FDA's Division of Metabolism and Endocrine Drug Products. This paper describes the new preclinical testing requirements and the rationale f...

    journal_title:Contraception

    pub_type: 指南,杂志文章

    doi:10.1016/0010-7824(92)90114-9

    authors: Jordan A

    更新日期:1992-12-01 00:00:00

  • An educational intervention on drug interactions and contraceptive options for epilepsy patients: a pilot randomized controlled trial.

    abstract:OBJECTIVE:This pilot study investigates whether an educational handout could increase short-term information retention about drug interactions between antiepileptic drugs (AEDs) and hormonal contraceptives among female epilepsy patients of reproductive age. STUDY DESIGN:This is a pilot randomized controlled trial of a...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2015.07.008

    authors: Mody SK,Haunschild C,Farala JP,Honerkamp-Smith G,Hur V,Kansal L

    更新日期:2016-01-01 00:00:00

  • Effect of a single vaginal administration of levonorgestrel in Carraguard gel on the ovulatory process: a potential candidate for "dual protection" emergency contraception.

    abstract:OBJECTIVE:The study was conducted to evaluate the effect of Carraguard vaginal gel containing 0.75 mg of levonorgestrel (CARRA/LNG gel) administered in a single dose at different stages of follicle development over subsequent follicle rupture and hormonal levels. METHOD:Randomized, blinded, cross-over study comparing ...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2007.04.005

    authors: Brache V,Croxatto H,Sitruk-Ware R,Maguire R,Montero JC,Kumar N,Salvatierra AM,Tejada AS,Cochón L,Forcelledo ML,Lahteenmaki P,Alvarez F,Faundes A

    更新日期:2007-08-01 00:00:00

  • Metabolic and endocrine studies in women using norethindrone acetate implant.

    abstract::Subcutaneously administered implant-D containing 40 mg of Norethindrone acetate in a single silastic implant was offered to 79 subjects who desired spacing of their family. The effect of constant release of steroid from this device on metabolic and endocrine functions was studied. Each subject in the pretreatment stat...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(79)80026-8

    authors: Shahani SM,Kulkarni PP,Bhate PA,Patel KL

    更新日期:1979-02-01 00:00:00

  • Treatment of pain during medical abortion.

    abstract::A structured literature review was undertaken to determine, in the context of early medical abortion, the proportion of women who require analgesia, the predictors of analgesia requirement and the most appropriate analgesia regimen. Studies from different centers show wide variations in analgesia use, but, overall, ar...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2006.03.002

    authors: Penney G

    更新日期:2006-07-01 00:00:00

  • Ovulation inhibition by a new low-dose progestagen.

    abstract::A new synthetic progestagen, Org 2969 (13-ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol) was administered to 9 healthy normally menstruating women. 3 subjects (Group 1) ingested .030 mg, while 6 (Group 2) ingested .015 mg of the compound daily on Days 1-20 of 1 menstrual cycle. The previous menstrual...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章

    doi:10.1016/0010-7824(77)90129-9

    authors: Viinikka L,Hirvonen E,Ylikorkala O,Nummi S,Virkkunen P,Ranta T,Alapiessa U,Vihko R

    更新日期:1977-07-01 00:00:00

  • A comparison of the effects of nonoxynol-9 and chlorhexidine on sperm motility.

    abstract::The effects of Nonoxynol-9 and chlorhexidine on sperm motility were compared using the objective Transmembrane Migration Ratio method. These agents were found to be of similar potency in inhibiting sperm motility. The concentrations which reduced sperm motility by 50% (EC50) were 0.205 mg/ml for Nonoxynol-9 and 0.215 ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(85)90108-8

    authors: Louis SM,Pearson RM

    更新日期:1985-08-01 00:00:00

  • Emergency contraception in Mexico City: what do health care providers and potential users know and think about it?

    abstract::Emergency contraception promises to reduce Mexico's high unwanted pregnancy and unsafe abortion rates. Because oral contraceptives are sold over-the-counter, several emergency contraceptive regimens are already potentially available to those women who know about the method. Soon, specially packaged emergency contracep...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(99)00088-8

    authors: Langer A,Harper C,Garcia-Barrios C,Schiavon R,Heimburger A,Elul B,Renoso Delgado S,Ellertson C

    更新日期:1999-10-01 00:00:00

  • Contraceptive failure in the United States.

    abstract::This review provides an update of previous estimates of first-year probabilities of contraceptive failure for all methods of contraception available in the United States. Estimates are provided of probabilities of failure during typical use (which includes both incorrect and inconsistent use) and during perfect use (c...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2011.01.021

    authors: Trussell J

    更新日期:2011-05-01 00:00:00

  • Fibrinolytic activity in plasma and vessels of the hind leg in rats treated with ethinylestradiol and D-norgestrel.

    abstract::The separate effect of ethinylestradiol (4 micrograms/kg b.w./day) and d-norgestrel (20 micrograms/kg b.w./day) on the fibrinolytic activity in plasma and in vessel walls of the hind leg was investigated in an experimental study on rats. No hormonal effect on the fibrinolytic activity in plasma was registered. However...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(84)90101-x

    authors: Kjaeldgaard A,Larsson B

    更新日期:1984-08-01 00:00:00

  • Assessment of contraceptive use in Puerto Rico during the 2016 Zika virus outbreak.

    abstract:OBJECTIVES:The objectives of this analysis were to 1) estimate prevalence of contraceptive use among women at risk for unintended pregnancy and 2) identify correlates of contraceptive use among women with ongoing or potential need for contraceptive services in Puerto Rico during the 2016 Zika virus (ZIKV) outbreak. ST...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2020.03.001

    authors: Ellington SR,Rodriguez RS,Goldberg H,Bertolli J,Simeone RM,Mercado AS,Pazol K,Jamieson DJ,Honein MA,Swartzendruber A,Miles T,Cordero JF,Shapiro-Mendoza CK

    更新日期:2020-06-01 00:00:00

  • Abortion misinformation from crisis pregnancy centers in North Carolina.

    abstract:BACKGROUND:This study assessed the accuracy of medical information provided by crisis pregnancy centers in North Carolina. STUDY DESIGN:We performed a secondary data analysis of a "secret shopper survey" performed by a nonprofit organization. Reports from phone calls and visits to crisis pregnancy centers were analyze...

    journal_title:Contraception

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.contraception.2012.06.001

    authors: Bryant AG,Levi EE

    更新日期:2012-12-01 00:00:00

  • Menstrual induction with mifepristone and misoprostol.

    abstract::Menstrual induction refers to early uterine evacuation without laboratory confirmation of pregnancy in women with delayed menses. Mechanical aspiration is the method used in many countries but, as suggested by a pilot study, mifepristone followed by a prostaglandin analogue could also be effective. We launched the pre...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/j.contraception.2003.09.009

    authors: Xiao B,von Hertzen H,Zhao H,Piaggio G

    更新日期:2003-12-01 00:00:00

  • Medication Abortion Up to 70 Days of Gestation.

    abstract::Medication abortion, also referred to as medical abortion, is a safe and effective method of providing abortion. Medication abortion involves the use of medicines rather than uterine aspiration to induce an abortion. The U.S. Food and Drug Administration (FDA)-approved medication abortion regimen includes mifepristone...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2020.08.004

    authors: Practice Bulletins—Gynecology, the Society of Family Planning.

    更新日期:2020-10-01 00:00:00

  • Task-shifting the provision of DMPA-SC in the DR Congo: Perspectives from two different groups of providers.

    abstract:OBJECTIVES:To document the experience of three groups of Family Planning service providers participating in task-shifting for the provision of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) at the community level in the DRC. STUDY DESIGN:This article compares results from interviews with DMPA-SC providers in...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2018.07.002

    authors: Hernandez JH,Akilimali P,Glover A,Emel R,Mwembo A,Bertrand J

    更新日期:2018-11-01 00:00:00

  • ORTHO birth control satisfaction assessment tool: assessing sensitivity to change and predictors of satisfaction.

    abstract:OBJECTIVE:To test the sensitivity to change of the ORTHO Birth Control Satisfaction Assessment Tool (ORTHO BC-SAT) among dissatisfied women switching to a new hormonal birth control method and to better understand which factors contribute to a woman's satisfaction with the method. MATERIALS AND METHODS:Women switching...

    journal_title:Contraception

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.contraception.2006.03.033

    authors: Mathias SD,Colwell HH,Lococo JM,Karvois DL,Pritchard ML,Friedman AJ

    更新日期:2006-10-01 00:00:00

  • Blood hormone levels in egyptian women on norethisterone oenanthate.

    abstract::Ten Egyptian women who were using the injectable contraceptive norethisterone oenanthate (NET-OEN) for at least 6 months were monitored weekly for a period of 12 weeks by measuring 3 pituitary hormones (FSH, LH and prolactin) and 2 ovarian hormones (oestradiol 17-B and progesterone). It was concluded that NET-OEN is a...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(83)80004-3

    authors: Saleh FM,Sallam HN,Abdel-Rahman H,Souka AR,El-Sahwi SY,Toppozada HK

    更新日期:1983-07-01 00:00:00

  • Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials.

    abstract::Changes in body weight and the incidence of estrogen-related side effects with low-dose oral contraceptives (OCs) containing 20 microg ethinyl estradiol (EE) have not been demonstrated in placebo-controlled trials. Two placebo-controlled, randomized trials demonstrated the efficacy of a low-dose OC for the treatment o...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1016/s0010-7824(01)00208-6

    authors: Coney P,Washenik K,Langley RG,DiGiovanna JJ,Harrison DD

    更新日期:2001-06-01 00:00:00

  • Effect of polyphloretin phosphate on the contraceptive action of a polyethylene intrauterine device in rats.

    abstract::A polyethylene intrauterine device (IUD) inserted in one horn of the rat uterus on Day 2 of pregnancy prevented implantation in 9 out of 12 rats in the horn with the device. When polyphloretin phosphate (PPP), a substance known to inhibit alkaline phosphatase, was administered to such rats from Day 1 till Day 5 of pre...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(83)90016-1

    authors: Chaudhury MR

    更新日期:1983-08-01 00:00:00

  • Changing disparities in teen birth rates and repeat birth rates in Georgia: implications for teen pregnancy prevention.

    abstract:OBJECTIVE:To understand teen birth trends in Georgia by racial and geographic factors. STUDY DESIGN:We analyzed overall birth and repeat teen birth rates by race, urban/rural status and adequacy of obstetric care from 2008 to 2016 using vital records from all Georgia counties. RESULTS:Overall birth rates among teens ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2018.11.007

    authors: Nandi P,Kramer M,Kottke M

    更新日期:2019-03-01 00:00:00

  • Lactobacillus species isolated from the vagina: identification, hydrogen peroxide production and nonoxynol-9 resistance.

    abstract:BACKGROUND:Lactic acid production is considered to be the major protection mechanism of lactobacilli against vaginal infections due to genital pathogens. Some species of Lactobacillus are also hydrogen peroxide (H(2)O(2)) producers. Nonoxynol-9 (N-9) is a nonionic detergent and is the active component of many spermicid...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2005.06.066

    authors: Pascual LM,Daniele MB,Pájaro C,Barberis L

    更新日期:2006-01-01 00:00:00